Factors influencing the efficacy of nebulized colistimethate sodium in the treatment of severe lung infection caused by carbapenem-resistant gram-negative bacteria
We confirmed the clinical benefits of a nebulized CMS-based regimen for treating severe pneumonia. Several influential factors were identified, which may help optimize the clinical use of nebulized CMS.
Authors
- Yu Fu (ORCID: https://orcid.org/0000-0003-0962-7152)
- Shuling Deng
- Zhan Gao (ORCID: https://orcid.org/0000-0003-0976-8836)
- Yongli Zhang (ORCID: https://orcid.org/0000-0001-7079-7973)
- Chuji Cheng
- Hao Xu (ORCID: https://orcid.org/0000-0001-6459-1063)
- Yanjing Xu
- Genhua Mu
- Lin Dou
- Zhiyu Wang
- M. Zhao
- Genjie Wang
- Dan Li
- Yuanyuan Yi
- Ran Li
- Shukun Chai
- Dong Zhang
- Yang Tao
- Chunmei Zhang
- Bing Dai
- Yan Gu
Institutions
- Dalian Medical University (CN)
- Jilin University (CN)
- Nantong University (CN)
- Peking University (CN)
- China-Japan Friendship Hospital (CN)
- First Affiliated Hospital of Xiamen University (CN)
- Fourth Affiliated Hospital of China Medical University (CN)
- Fifth Tianjin Central Hospital (CN)
- Shangqiu First People's Hospital (CN)
- Yancheng First People's Hospital (CN)
- First Hospital of Shijiazhuang (CN)
- Peking University People's Hospital (CN)
- First Hospital of Jilin University (CN)
- Anqing City Hospital (CN)
- Chongqing Emergency Medical Center (CN)
- First Hospital of China Medical University (CN)
- First Affiliated Hospital of Dalian Medical University (CN)
- Affiliated Zhongshan Hospital of Dalian University (CN)
- Ningbo University Affiliated Hospital (CN)
- Wuxi People's Hospital (CN)
- Ningbo First Hospital (CN)
- Inner Mongolia Medical University (CN)
- China Medical University (CN)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2026-03-01
- DOI
- https://doi.org/10.1016/j.ijid.2026.108588
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 0.00